ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 845 filers reported holding ISHARES TR in Q1 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $599,187 | -15.8% | 4,900 | -12.6% | 0.06% | -31.3% |
Q2 2023 | $711,906 | -10.6% | 5,607 | -9.1% | 0.08% | -12.6% |
Q1 2023 | $796,653 | +31.9% | 6,168 | +34.1% | 0.10% | +18.8% |
Q4 2022 | $603,902 | +4.7% | 4,600 | -6.8% | 0.08% | -8.0% |
Q3 2022 | $577,000 | -27.2% | 4,933 | -26.8% | 0.09% | -26.3% |
Q2 2022 | $793,000 | +8.3% | 6,742 | +20.0% | 0.12% | +22.9% |
Q1 2022 | $732,000 | -1.5% | 5,618 | +15.5% | 0.10% | -2.0% |
Q4 2021 | $743,000 | -3.4% | 4,866 | +2.2% | 0.10% | -11.7% |
Q3 2021 | $769,000 | -16.1% | 4,759 | -15.2% | 0.11% | -0.9% |
Q2 2021 | $917,000 | -56.9% | 5,609 | -60.3% | 0.11% | -68.1% |
Q1 2021 | $2,129,000 | +1.8% | 14,146 | +2.5% | 0.35% | -20.0% |
Q4 2020 | $2,091,000 | -99.7% | 13,803 | +161.6% | 0.44% | +18.6% |
Q3 2020 | $737,132,000 | +8.3% | 5,276 | +8.7% | 0.37% | -1.9% |
Q2 2020 | $680,577,000 | +117.0% | 4,852 | +66.7% | 0.38% | +88.5% |
Q1 2020 | $313,567,000 | -6.8% | 2,910 | +5.5% | 0.20% | -1.0% |
Q4 2019 | $336,497,000 | – | 2,759 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |